Intrinsiqq
Pharming Group N.V. ADR logo

Pharming Group N.V. ADR

PHAR

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$859M
EPS$0.12
P/E92.68
P/FCF25.01
EV/EBITDA32.58
FCF Yield4.0%
Div. Yield–
Net Debt/FCF-1.8x
Pharming Group N.V. ADR intrinsic value
52-Week Range
$9.11$21.18

Profitability & Returns

Revenue (TTM)

$366M

▲ +26.6% YoY

Net Income (TTM)

$9M

▲ +121.4% YoY

Op. Margin

3.37%

▲ +6.8pp YoY

ROIC

2.88%

▲ +3.7pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$34M

▲ +2182.3% YoY

Op. Cash Flow (TTM)

$35M

▲ +471.2% YoY

Net Debt

-$63M

Net Cash Position

Cash & Equiv.

$179M

3Y CAGR: +22.3%

3Y CAGR: +38.1%

Continue Research

Peers

Biotechnology · Pick stocks to compare with PHAR

CompareIntrinsic value
M12.XETRM1 Kliniken AG
€18.62-4.51%91
CARA.XSTOCarasent AB
€2.14-0.70%54
PPGN.XSWXPolyPeptide Group AG
No recent price30
PAX.XSTOPaxman AB
€6.00+2.92%39
MLECMoolec Science SA
No recent price10
SKAN.XSWXSKAN Group AG
No recent price33
CANTA.XSTOCantargia AB
€0.08+0.24%54
EUZ.XETREckert & Ziegler SE
€14.48-1.83%74

Pharming Group N.V. ADR (PHAR) in four numbers

Fair value (earnings)
$2.32
Price $11.54 is 398% above it.
Intrinsic Value
Quality score
56/100
Best check: revenue growth, 15.5%. Weakest: return on capital, 2.9%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
92.68
Price to free cash flow 25.01.
Financials

Questions about Pharming Group N.V. ADR

Is Pharming Group N.V. ADR (PHAR) overvalued?

At $11.54, Pharming Group N.V. ADR's price is 398% above the $2.32 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 92.68 times earnings and 25.01 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Pharming Group N.V. ADR's fair value?

Intrinsiqq's calculator puts Pharming Group N.V. ADR's fair value at $2.32 a share. It grows earnings per share 0% a year for 5 years, applies an exit P/E of 30, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $1.74. Every input can be changed on the Intrinsic Value tab.

Is Pharming Group N.V. ADR a high-quality business?

Pharming Group N.V. ADR scores 56 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 8 checks computed from company filings. Its best check is revenue growth at 15.5%, and its weakest is return on capital at 2.9%. The Quality tab shows every check against its target.

Does Pharming Group N.V. ADR (PHAR) pay a dividend?

No. Pharming Group N.V. ADR (PHAR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PHAR

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.